The litigation alleges that Microvast misled shareholders by overstating its ability to meet margin targets and failing to disclose significant operational hurdles. Specifically, the suit claims the company concealed inventory management issues and delays in commercial vehicle rollouts, alongside unrealistic projections regarding the completion of the Huzhou Phase 3.2 expansion facility.

Those who acquired shares during the specified period may seek compensation through a contingency fee arrangement, meaning no out-of-pocket costs for participants. Interested parties can contact Phillip Kim at the Rosen Law Firm to join the action. While a class has not yet been certified, investors retain the right to select their own counsel or remain absent members of the class without impacting their ability to share in a potential future recovery.